アジア太平洋地域における感染症POCT (臨床現場即時検査) 市場の予測：～2023年
Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023
|発行||Frost & Sullivan||商品コード||866656|
|出版日||ページ情報||英文 74 Pages
|アジア太平洋地域における感染症POCT (臨床現場即時検査) 市場の予測：～2023年 Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023|
|出版日: 2019年06月07日||ページ情報: 英文 74 Pages||
アジア太平洋地域における感染症POCT (臨床現場即時検査) の市場は結核、HIV、肝炎の罹患率の上昇、携帯型POCT機器の開発などの要因によって推進される見通しです。
当レポートでは、アジア太平洋地域における感染症POCT (臨床現場即時検査) の市場を調査し、市場の背景・概要、バリューチェーン、市場成長への各種影響因子の分析、主な市場動向・技術動向、主要5カ国の展望、疾患領域別の収益規模の推移と予測、競合環境と市場シェア、成長機会・成功因子の分析などをまとめています。
The Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices will Propel the APAC Infectious Diseases POCT Market
This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests.
The Asia-Pacific shows the highest prevalence of infectious diseases, such as tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs). Countries such as India, China, and Indonesia are some of the leading contributors to these life-threatening infections. Hence, the Asia-Pacific stands out as a key contributor to the global infectious diseases diagnostics market.
With the rising disease prevalence, companies are shifting their business models to a more consumer-oriented approach. Steps are being taken to ensure a direct contact with the consumer/end user by means of direct-to-consumer selling using ecommerce portals such as Amazon. Alongside retail selling, vendors such as Alibaba ensure a bulk dispatch of diagnostic devices to hospitals and clinics, thereby playing a crucial role in the diagnostic value chain. The study also highlights some of the innovative payment models which result in improved patient access to these high value therapies. Information on some of the emerging business models across the cell therapy market, such as risk sharing, fast to market business models, etc., has also been provided.
The study aims to identify some of the key growth opportunities which are set to drive the market in the next few years. It provides a revenue analysis of the total Asia-Pacific infectious diseases POCT market with an analysis of the specific regional players as well as the most common infectious disease diagnostics. The study also highlights some of the key market drivers and restraints which affect the growth. Additionally, it gives an insight on the leading market trends shaping the industry and their long-term implications on market growth. It also focuses on some of the country-specific regulatory policies and their impact on the adoption of innovative diagnostics solutions.